NCT05664659View on ClinicalTrials.gov

Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 20, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

May 20, 2023

Conditions
Blood Loss, SurgicalIntrapartum Hemorrhage
Interventions
DRUG

Oxytocin + misoprostol

600 micrograms misoprostol rectally 20 IU Oxytocin IV infusion on 1000 ml of normal saline solution

DRUG

Carbetocin

100 micrograms carbetocin

Trial Locations (1)

Unknown

Ain Shams Maternity Hospital, Cairo

All Listed Sponsors
lead

Ain Shams Maternity Hospital

OTHER